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ABSTRACT

Avian animal models have led to many essential discoveries in molecular biology and
biochemistry, including the discovery of vitamins, the chemistry behind vision and the
development of transgenic hens as natural bioreactors for pharmaceutically relevant
proteins. Hyperovulation in domesticated hens is considered a highly desirable genetic
trait, a feature that has been explored in multiple studies and remains the focus of many
biotech companies. Unlocking the molecular mechanism that controls ovulation may
provide a basis for development in new reproductive technologies.
Previous research done on rodents provided data and identified a single transcription
factor, the Inducible cAMP Early Repressor (ICER), found to directly mediate the
nuclear response to gonadotropins and trigger hyperovulation. Transgenic mice carrying
tissue-specific FSH-inducible ICER construct showed two-fold ovulation rate increase
following hormonal activation of the cAMP second messenger relay.
In this study, I focus on generation of a transgenic construct derived and specific for
the domesticated hen, Gallus gallus. For this purpose, I amplified the 3kb promoter
sequence of the Inhibin-a subunit gene. I also subcloned the avian homolog of the ICER
Iy isoform to the pFLAG-CMV-2 plasmid and created the FLAG-gg-ICER Iy transgene
construct. The DNA sequencing analysis showed successful amplification of gg-ICER Iy
Following transfection into 293T (Human Kidney Carcinoma cells), the Western Blot
analysis identified gg-ICER Iy expression under control of CMV promoter.
I am now focusing on subcloning the Inh-a-FLAG-gg-ICER Iy transgenic construct
onto an expression vector and perform functional analysis in cell culture. Last, my goal
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would be to utilize a lenti-viral delivery vector to infect fertilized Gallus gallus eggs.
Using a well established signaling pathway, my hypothesis is that the extracellular
signals of the Follicle Stimulating Hormone (FSH) will trigger changes in gene
expression that will induce hyperovulation. This molecular mechanism would provide
evidence for the complex interaction between the reproductive tract and the central
nervous system.
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INTRODUCTION
The domesticated hens aided the discovery of essential vitamins and provided specific
clues to the differences between T and B cells. Used as natural therapeutic protein
bioreactors, the avian remains one of the primary animal models used in research (Lillico et
al., 2007, Petltte and Mozdzlak, 2007). From a practical perspective, the domesticated hens
contributed a great deal to the market solutions of the increase in food demand.
Hyperovulation in domestic hens remains a highly desirable genetic trait and focus of
biotech companies. Related but not limited to the global food crisis and production of costaffordable therapeutic proteins, developing transgenic lines of domesticated hens may also
provide the basis for development of new reproductive technologies (Lillico et al, 2007).
Ovulation in mammals is controlled by the cyclical action of hormones, specifically
gonadotropins FSH and LH (Molina et al. manuscript in preparation). Hormonal regulation
of the cell cycle by gonadotropins FSH and LH is crucial for folliculogenesis, ovulation
and luteinization (Muniz et al., 2006). Changes in gene expression in response to FSH and
LH directly control the progression of the ovarian follicular development (Burkart et al,
2005). Maturation of the follicles requires proliferation and differentiation of the follicular
cell compartment. Following hormonal activation of the cAMP relay, coordinated gene
expression between these two processes must be tightly regulated (Molina et al,
manuscript in preparation).
cAMP is found to be one of the most prevalent signaling molecules that regulates
gene expression (Burkart et al, 2005). Many hormones use cAMP as a secondary
messenger to control gene expression in target cells by activating cAMP responsive
proteins (Mukherjee et al, 1998). The intracellular cAMP relay mechanism plays a central
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role in essential processes such as cell proliferation, cell differentiation and apoptosis
(Sandrine et al., 1997). Elevated levels of cytoplasmic cAMP initiate phosphorylation of
nuclear factors used for transcriptional control, thus regulating specific gene expression
(Sandrine et al, 1997). The activation of genes by cAMP so far is explained by the
presence of cAMP-response elements (CREs) that serve as binding sites for cAMP
activated proteins. The CRE is constituted by an 8bp palindromic sequence (TGACGTCA)
(Fazia et al., 1997).
CRE-binding protein (CREB) and CRE-modulator protein (CREM) are members of
the bZIP family of transcription factors that have been best characterized up to this date.
Upon phosphorylation, the bZIP activated proteins bind to specific CREs located in the
promoter of cAMP responsive genes and activate transcription (William et al., 1998).
Alternative RNA processing of CREB and CREM family of transcription factors creates
protein isoforms that can act as activators and repressors (Burkart et al., 2005). One of
those downstream nuclear factors is the Inducible cAMP Early Repressor (ICER). ICER is
found to play a crucial role in multiple processes including cell survival/death (Sandrine et
al., 1997), circadian control of transcription in the pineal gland, cyclin A expression in
insulin producing b-cells (Inada et al., 2005), cell-cycle control in fibroblast and FSH
receptors expression in sertoli cells (Folco and Koren, 1997). Transcription of ICER is also
regulated by cAMP signaling as an internal P2 promoter located in the 3’ region of the
CREM gene is activated and regulates ICER expression (Molina et al., 1993, William et
al., 1998). The four ICER isoforms are the smallest CRE-binding nuclear factors described
to date (Morales et al. 2003). ICER and the rest of CREM isoforms share the DNA binding
and dimerization domains but lack the kinase and transactivation domains (Muniz et al.,
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2006). ICER has been implicated in the transcriptional repression of FSH inducible genes
during the process of folliculogenesis (Molina et al., manuscript in preparation). The
gonadotropins FSH/LH-cAMP-ICER cascade has been proposed to have dual mode, to
activate or repress cell cycle progression in the ovaries, hence regulating folliculogenesis
and ovulation. ICER plays a key role as a dominant negative transcriptional repressor
binding as homodimer or heterodimer to CRE sequences located on the promoter region of
target genes (Molina et al., 1993, Muniz et al., 2006).
LH mediated expression of ICER in granulosa cells is found to downregulate Inhibina subunit gene expression just before ovulation. Downregulated Inhibin-a subunit gene
expression leads to prolonged FSH surge that is crucial for recruitment of additional
ovarian follicles (Mukherjee et al, 1998). EMSA’s and transfection studies identified all
ICER isoforms being capable of binding and repressing Inhibin-a subunit gene. In different
cellular events, CREB and ICER show competitive action for binding Inhibin-a subunit
CRE-like element as a result of FSH and LH stimulus, respectively. Replacement of CREB
by ICER may be the final event in repression of Inhibin-a subunit gene (Burkart et al.,
2005). A basic pattern of FSH stimulation and LH repression during the estrous cycle was
examined multiple times for a number of genes expressed in the ovaries (Mukherjee et al,
1998). Gonadotropins induced regulation of gene expression in rat ovaries was examined
by in situ hybridization using radiolabeled CREM antisense riboprobe and riboprobes for
the shorter repressor forms like ICER (Mukherjee et al, 1998). CREM and ICER
expression in response to gonadotropins closely correspond. However, there were data
showing selective activation of the P2 promoter that specifically generates the four ICER
isoforms. In addition, the time sequence analysis showed that ICER regulation is directly
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Figure 1: CREM and ICER isoforms - CREM gene contains two promoters, PI and P2,
regulating expression of 11isoforms, transcriptional activators and repressors. The P2
promoter regulates expression of 4 repressors, the only inducible isoforms of CREM. The
graphical representation shows that CREM and ICER share the DNA binding and
dimerization domains but lack the kinase and transactivation domains.
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controlled by LH surges, upregulated and downregulated in specific time intervals. The
actual relationship between ICER expression and Inhibin-a subunit downregulation in
response to LH was still not confirmed. The Western Blot data identified a close
relationship of ICER peak expression at 4h after hCG treatment, a time period when
Inhibin- a subunit mRNA levels dramatically begin to decrease. Electrophoretic mobility
shift assays identified ICER as a component of a larger complex attached to the Inhibin
alpha-subunit CRE. Comparative analysis of ICER I sense and antisense construct were
performed to test ICER ability to suppress Inhibin-a subunit gene expression. While the
antisense construct had no effect, ICER I sense construct reduced the promoter activity thus
downregulated Inhibin-a subunit gene expression (Mukherjee et al, 1998). Hormonally
activated cAMP mechanism of cell signaling is found in many tissues and cell types
(Mukherjee et al, 1998). The multiple genes involved, such as CREB and CREM and their
many isoforms, along with the alternative RNA processing, phosporylation and the
posttranslational modifications exponentially increase the overall effects of these nuclear
factors. Such effects may be analyzed in a tissue or a cell specific manner.
Various ICER target genes have been reported in recent studies. Cyclin D2 (Ccnd2) is
found to mediate folliculogenesis in response to FSH. Transgenic mice having Ccnd2 null
mutation show impaired granulosa cell proliferation (Muniz et al, 2006). Cyclins (Dl, D2
and D3) belong to a family of cell cycle regulators involved in the Gl/S phase transition,
they activate genes involved in DNA synthesis and have been shown to be crucial for
proper follicular development (Muniz et al, 2006). Also, Cyclin D2 levels are found to be
elevated in human granulosa cell tumors. The levels of Ccnd2 are reduced after LH/hCG
surge. The proposed repressor of Ccnd2 is most likely to be the short isoform of CREM,
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ICER. The Cyclin D2 mRNA levels have been shown to be induced by FSH via
cAMP/PKA pathway and are rapidly decreased by LH (Muniz et al, 2006). Expression of
P450-arom in response to FSH is essential in granulosa cell differentiation (Morales et al,
2003). P450-arom is a product of CYP19 gene and its expression can be detected in several
tissues: human placenta, brain, adipose and gonads. The coding region of CYP19 is
identical in every tissue. FSH activates CYP19 expression in ovaries due to the presence of
CLS (CRE-like sequence) that puts in use the cAMP-dependent inducability of the ovarian
promoter. The mechanism of downregulation of the P450-arom may be investigated by
FH-induced ICER- suppression of the CYP19 promoter that controls P450-arom
expression (Morales et al, 2003). The importance of the cAMP signaling and the cAMP
inducible genes has been broadly studied in context of hepatectomy, diabetes and
epileptogenesis. Sassone-Corsi et al. have identified cAMP as an essential second
messenger in liver as well as the role of CREM in liver regeneration (Sassone-Corsi et al,
2002). In addition, ICER I-y was found to be greatly increased in diabetes, directly
repressing cyclin A gene expression. More importantly, the overall potential effect is the
anti-proliferation in min6 cell line which has been identified as insulin producing cell line
(Inada et al, 2005). Studies on pineal gland identified ICER as negative regulator of
cAMP-driven transcription of genes involved in the circadian FIX rhythm (Xiadong et al,
1998). ICER may have a specific function in apoptosis of neurons presumably by
downregulating expression of anti-apoptotic genes. Adenoviral vector delivering ICER
overexpresion evokes programmed cells death in three different kinds of cultured neurons
(Jacek et al, 2003, Nicholas et al, 1997). Following status epilepticus, the mRNA and
protein levels of ICER in neurons are found to be increased (Porter et al, 2008). Recent
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advances in the field of neuroscience provided more sophisticated approaches for studying
genes and proteins involved in neurosignaling, brain development and neuronal
regeneration. Porter et al. studied CREM and ICER mode of action following status
epilepticus (SE). Increased expression of CREM and ICER following pilocarpine induced
status epilepticus may be one of the neuronal defense mechanism (Porter et al, 2008).
Collectively, these reports include wide expression pattern of ICER related to
multiple tissues and tissue specific processes. Transcriptional regulation of ICER with a use
of a tissue specific and closely regulated promoter can thus be used to fight diabetes or
epilepsy and provide additional information for the mechanism of mammalian
reproduction at molecular level. In this study and based on data collected on rodents
carrying transgenic ICER, I focused on generation of the Inh-a-FLAG-gg-ICER Iy
construct derived and specific for the domesticated hen, Gallus gallus. My perspective was
derived from several key benefits from developing an avian model carrying ICER
transgenic construct regulated by an ovarian-specific transgenic promoter. Using a well
established signaling pathway, my hypothesis is that the extracellular signals of the Follicle
Stimulating Hormone (FSH) will trigger changes in gene expression that will induce
hyperovulation. To confirm the regulatory mechanism in addition to the cloning of the
transgene I perform several Q-RT-PCR experiments to test the Inh- a subunit gene
expression pattern using mouse-derived cDNA. The selected animals carried the ICER
transgene specific for mice and were confirmed to have ICER overexpression. Comparing
the expression levels of Inh- a subunit gene in transgenic and wild-type mice I may be able
to confirm the molecular mechanism that regulates ovulation and provide evidence for the
complex interaction between the reproductive tract and the central nervous system.
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MATERIALS AND METHODS

RNA/DNA Extraction
Both RNA and DNA were extracted from frozen chicken ovaries using the TRIzol Reagent
(Molecular Research Center, Cincinnati, OH) according to the manufacturer’s instructions.
Tissue from multiple ovaries was collected and a total of 39 DNA and 18 RNA samples
were purified. Both RNA/DNA integrity was confirmed by agarose gel electrophoresis
with ethidium bromide staining. The RNA/DNA concentration was measured before each
experiment by using the NanoDrop (Thermo scientific) spectrophotometric analysis
method.

PCR amplification of Inhibin-a subunit gene promoter
PCR was used to amplify the Inhibin-a subunit gene promoter sequence of 3049bp
(Textbox 1). AccuPrime DNA Polymerase for GC-Rich templates (Invitrogen, Cat Nu.
12337-016) was used and all reactions were performed according to the manufacturer’s
protocol and cycling parameters. DNA concentration was adjusted for a range of lOng100ng final concentration with diH20 following a Nanodrop reading for each specific
extract. The following oligos were used: Forward 5’- GCTCCGCCACCTCCACGTCC - 3’
and Reverse 5’- GGCCGTGGGGCAGCTCAAGG - 3’. Re-amplification experiments
were performed using two additional enzymes, the HotStart Tag-Plus DNA polymerase
(Qiagen) and the HotStart Mastermix (Denville Scientific). Each enzyme was used for the
PCR amplification according to the manufacturer’s protocol, using the specified amounts
of reagents and cycling parameters. All reactions were set for 25pl final volume.
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RT-PCR amplification of gg-ICER Iy
PCR with reverse transcription was used to generate chicken ICER (GenBank AF509471).
AccessQuick RT-PCR system (Promega) components were prepared as indicated in the
manufacturer’s protocol for a total volume of 50pl per reaction. Primers we specifically
designed the amplify the ICER mRNA based of the NCBI data (AF509471) : Forward 5'ATGGCTGTTACAGGAGATGA-3' and Reverse 5'-TTATTCTGCTTTATGACAAT-3'.
Reverse transcriptase was added to the reaction tubes followed by 45min incubation at
45°C. AccessQuick DNA polymerase was then added and PCR parameters were set as
directed by the manufacturer. 2% agarose gel electrophoresis was performed to verify the
size of the initial 327bp fragment.

Topo TA Cloning and Restriction Digest
The RT-PCR amplified ICER Iy fragments were ligated onto a pCR 2.1 TOPO cloning
vector. 6pl Topo cloning reactions (Invitrogen) were prepared using the volumes and
components according to the manufacturer’s instructions. Following 5min room
temperature incubation, 2pl of each cloning reaction was added to a vial of OneShot Top 10
chemically competent cells. Cells were incubated on ice for 30min and heat-shocked for
30sec at 42°C. 250pl of pre-warmed S.O.C. medium was added following lhour incubation
at 37°C. Cells were spread on LB w/ ampicillin selective plates and grown overnight.
Growing colonies indicating successful integration of the ICER fragment onto the TOPO
vector were picked and grown in 3ml LB medium at 200rpm overnight. 1.5ml aliquots
were collected and centrifuged for lmin at 12000rpm. Plasmid DNA was purified using the
QIAprep Miniprep Kit (Qiagen) and according to the manufacturer’s protocol. Plasmid and
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RT-PCR fragments were digested w/ EcoRI, XbaRHindlll and Xbal/Bglll supplemented
with the appropriate buffers.

Sequencing of the pFLAG-CMV-2-gg-ICER Iy construct
Following the restriction digest, ICER Iy was cut off from the pCR 2.1 Topo and was
excised from the gel piece. Gel extraction was performed using QIAquick Gel Extraction
Kit (Qiagen) followed by an agarose gel electrophoresis confirmation and NanoDrop
concentration analysis. The purified ICER fragment was then ligated onto pFLAG-CMV-2
expression plasmid. lOpl reactions were prepared using T4 ligase (Sigma). Ligation
reactions were incubated overnight at 16°C. OneShot ToplO chemically competent cells
were transformed on LB plates w/amp. Samples that developed viable colonies were sent to
GeneWiz for sequencing (Sanger Method). CMV-Forward 21mer primer was used: 5’CGCAAATGGGCGGT AGGCGTG-3 ’

Cell Transfection
Two plates (6 wells each) were prepared for DNA transfection. Each plate contained ICER
Iy, however, the pSV40-ICER Iy had the mouse homolog of ICER and was used as control.
The pFLAG-CMV-gg-ICER Iy plasmid carried the Gallus gallus ICER Iy. Human Kidney
Carcinoma 293T cells were trasfected following 3 different protocols: lipofectamine
(Invitrogen), Ca-phosphate (Sigma) and lipofectamine (Sigma). Cells were incubated for
-48 hours, w/ one time medium change in intervals indicated by each protocol respectively.
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SDS-PAGE and Western Blot
Transfected cells were harvested approximately after 48hour incubation. Both dishes were
washed w/ 1ml cold HBSS twice. Cells were then scraped in 1ml ice-cold PBS and
transferred to a 1.5ml tubes, followed by a lmin spin at 14000rpm. 300pl IX Lammli
buffer (62.5mM Tris, pH 6.8, 2% SDS, 10% Glycerol, 5% mercaptoethanol and 0.001%
bromophenolblue) was added to each sample. Samples were then heated for 5min at 100°C
heating block and the centrifuged for lOmin at 14000rpm. After quick vortex, samples were
centrifuged for another 3min and supernatant was collected for SDS-PAGE. 6X loading
dye was added to each sample. IX running buffer was diluted from 10X stock (30.3g Tris
base, 144g glycine, lOg SDS for a final volume of 1L). 30pl of each sample was loaded and
the apparatus was set to run for 60min at 200V. Membranes were prepared according to the
manufacturer’s instruction (Western Breeze, Invitrogen) and soaked into transfer buffer
(3.03g Tris, 14.4g glycine, and 200ml methanol for a total volume of 1L). System was run
overnight at 30V. Anti-ICER (primary) and secondary AB’s + stain were added to the
nitrocellulose paper containing the transferred proteins.

Inhibin-a subunit gene promoter subcloning onto Topo II-Blunt and pFLAG plasmids
PCR amplified Inh-a sequence was ligated into TopoII-Blunt vector. Three separate
reactions were prepared using 1, 2 and 3pi PCR-amplified DNA, lpl salt solution and lpl
TopoII-Blunt plasmid. The reaction final volumes were adjusted with diH20 for a total of
6pl. Following a 30min room temperature incubation, 2pl of each reaction was pipeted into
a 50pl vial of OneShot competent cells and incubated on ice for 15min. The cells were then
heat-shocked in 42°C water bath for 30 sec, followed by addition of 250pl S.O.C. medium
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(pre-warmed). Reaction tubes were then incubated in 37°C shaker for 1 hour at 200rpm.
200ul of each reaction was platted onto LB plates with kanamycin. Plates were incubated
overnight at 37°C. Using the same DNA, another set of reactions was prepared using
pFLAG-CMV-2 plasmid. An important change made to this plasmid was the excision of
the CMV promoter sequence using HincII enzyme. It is now possible to use the plasmid to
directly ligate Inh-a promoter sequence. The pFLAG-CMV-2 plasmid also contains the
ICER Iy gene in the multiple cloning site ligated between the two EcoRI sites. The
reactions were prepared using 3pi plasmid DNA (ND concentration reading was lOng/pl),
lpl insert DNA, lpl 10X ligation buffer, 0.5pi lOmM ATP solution, 4.5pl PEG and 2pl T4
ligase. Reaction tubes were incubated overnight at 16°C. Collected colonies of each set
were grown in 3ml LB medium at 37°C overnight at 180rpm. LB medium was prepared
using ampicilin or kanamycin according to the plasmid selection gene.

Plasmid DNA Miniprep and Restriction digest
Plasmid DNA was later prepared using the QIAgen Miniprep kit according to the
manufactures specification. lOpl of the final 50pl purified DNA were used for restriction
digest using EcoRI restriction enzyme, in order to cut-off the insert from the plasmid.
Reactions were set using lOpl plasmid DNA, lpl EcoRI and lul 10X EcoRI-specific
buffer. The digest reaction was incubated in water bath at 37°C overnight. The samples
were then run on 1% agarose gel using 2pl 6X loading dye and lOpl (per gel box) EtBr.
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Q-RT-PCR for w.t. and transgenic gapdh and Inh-a subunit gene cDNA derived from w.t.
and transgenic mice
The Q-RT-PCR amplification of two mouse-derived genes, the house-keeping gapdh and
the Inh-a subunit gene, was carried out using the Sybr Green Master Mix. The reactions
using primers specific for both genes were prepared using 12.5pi 2X Sybr Green MM, 2pi
primer mix (0.8uM each primer), 0.5pl template cDNA and lOpl diH20 for a final volume
of 25pi per reaction. The cycling parameters were set for a 10min initial dénaturation at
95°C, followed by 40 cycles of 40sec at 95°C, lmin at 55°C and 40 sec at 72°C. Stratagene
MX3000P instrument and analysis software was used. The following oligos were used:
gapdh left 5’-ATGTTCCAGTATGACTCCACTCACG-3’ and gapdh right 5’GAAGACACCAGTAGACTCCACGACA-3’, Inh-a left 5’CTGTGCCTGTGTCCTTGGTA-3’ and Inh-a right 5’-CCAGGAAAGGAGTGGTCTCA3’. All primers were specific for the mouse homologs of the respective genes (Molina et
al, manuscript in preparation)
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RESULTS

In Silico analysis data
The NCBI and the EBI GenBank were the main databases used to locate and analyze both,
Gallus gallus Inhibin-a subunit gene promoter and ICER sequences. Both queries were
based on known rodent sequences (Molina et al., manuscript in preparation) and aligned for
similarities for the chicken genome. The Inh-a promoter sequence was found on the
European Bioinformatics website and was 3049bp long. 1lObp from the 3’ end of the
sequence we were able to confirm the non-canonical CRE element (textbox 1,yellow hilight). The chicken ICER Iy sequence was available on the NCBI website. Accession
number AF509471 query (Gallus gallus ICER Iy mRNA, complete CDS) identified the
mouse ICER Iy sequence as the closest match with 94% (textbox 2).
In addition to the sequence analysis and alignment data from NCBI, we performed
several analyses using the NebCutter V2.0 software from New England Biolabs
(http://tools.neb.com/NEBcutter2/index.php) to determine restriction sites found on both,
Inh-a gene promoter (fg.3) and gg-ICER Iy sequences (fg.5). The collected data were used
in the following restriction digest and restriction mapping experiments, mainly used to
verify amplification and ligation efficiency. In addition, the specificity of restriction sites
located on each sequence of interest, was used to verify orientation of the specific parts of
the transgene construct on each plasmid. All these data were also incorporated and used to
analyze restriction sites not present on the plasmid’s Multiple Cloning Site (MCS) but
found on the plasmid’s circular DNA sequence. Performing sequence analyses (fg.2) I was
able to confirm the high GC content of the Inh-a subunit gene promoter, a value of 66%
which was our main consideration when setting the PCR reaction and cycling parameters.
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5’GCTCCGCCACCTCCACGTCCTCCAGCGGCACCTGGAACCGCAGCCGGTGCTCTGCCACCGGGAGAGATGGGAGCTG
AGGGTGCTCAGCATCCTCCTGCTCAGCACCCTTCTGGTCCCCTGAACGCCCCCCCTGAGAGCACCCACGCATGCAGCG
CCCCCGCATTCCTCCCACATTGACAGTACGGCTGTGGGGAAGGAAGATGGCAGCCCCCCGTTCCCAGCAGCTATTTTG
GGATGTGGCAGCTGGGCGGGAGGCATTCGGTATGGGGCCTCAGGGCGCACAGCCCCCATGCAGGGGATCCAGCGTGG
CCCCGGGGCGCACACCTACCCTTCACCTGCAGCTGCACAGCACTCAGTGTCTGCCCGGCCGTGTTGGAGGCTGTGCAA
ACATACAGCCCCTGGTCCCGGGGCCGGCAGTACAGCACCTTCAGGATGAAGTAGCCCTCGCGGTCCTCGTAGATCAG
GTGCCGGCGGCCGGGGGCCACGGCCTTGCCATCCTTTTGCCAAATGATCTCTGGCTTGGGCTTGCCAGTGACATAGCA
GCGGAACTTGGCGTGCTTCCCCGCGCTGACGGCGAACGCCTTGGCTCTTGGCGTGCCGTTGGGTGCCGGCGCCCAGGT
GTCGGTGCATGCGTGCCGCAGTCTCCGCGGCTGGGTGCTGTCAGAAGGGGAGCACCGGGGCTCCACCAGGAGCACAG
CCGCAGCCAGGGCCTCCTTGGAGCCGCTGCGTGCCCGGCACACATAGACCCCCGCGTCTGGGGGCCGGACCCCAAAC
AGCTTAAGGTAATGCCAGTCCTCAGGCTGCCGGCCCACTGCAAAGTGGCTGCTCTCAAAGAGGTCACGCAGCCTGTG
GCCGTCCTTCTCCCACACGAGCAGCGGGCAGGGCTGCCCCAGCACTCGGCACGAGAAGGTCGAATCNNNNNNNNNN
GATGCTCCTCAGCCTCCACTCGCAGCGTGGCGGCAGCGTAGGTCTCGCCAACGCAGTTCTTGGCCTTGCAAACATAGA
GGCCGCCATCCTGCGGGGTGACGCAGGACACCCGTAGGCTGTACATGTCCCCCTCAGCCTCCATGCAGAAGCGGCCC
GAGGGCTGGATCGGGGCTGTGTCCTTCTCCCAGAGGACGCTGGGCCGGGGGTCACCTGCGATCTGGCACCTCAGCAT
GGCGTCGGTGCCGCTTTGTGCCGTGAAGGCGCGTGGGTAGGCCAGGAACCGAGGGGCTGCCCCATGGCTCTCCATCA
CCCTGGGATCGGGGCAGGAGGACGGCCAAGAGCTTCAGGCTGAGGACAGAGAGCGGCGTCAGGCTGTGGTGCGGGG
CATCCCACCCACAGCAATGCCACGTCAAGCCCAGGCTGGGAGGTGGGACCTGCCCGTGGGGCACGGGGCTCGCTGGG
TCCCTGCAGTGCTGGGGATGGGGTTGGCTGAGGAAGAACGGGCCCCAGCACGGCCCTTCCCCACCCGCTGGGGCATT
CCTGCAGTATCGGGTGGTGGCAGAGCCACATTCCTGCCGCATCTGGGCTGGCTCAGTGCACAGGTGCTGATAAGGGG
CTGTCATGGGGCTGGAGGCATCCGGATGCATCCGGGTGCTTCCTGCCCGGCTCAGCAGGGTGCATGGGAAGAGGACC
CCCGCCCGAGCGTGGTCCCAACTCCAGCCCCTGCGTGTCCAAGGCCAGGACTGGACATCACCGCAGGGTGCAGAGGG
CCAAACAGGGAACAAGTCCTGCTTTCGGAGGGTATCACCTCCACACCCAGTGCTGCAGGTACCCGTGCCCAGCACCA
CGGGCAGCAGAAGGGCTCTGTGCTTGAAGCCTTTCCTGGGCAAGCATAAACCTCAGCCCCTGCCCGTGCTGCACCCAG
GGGTGGACAGAGGCATCTATGCCTCCCTCAGGGAGAGCAGGGACAAAGAGAAACCCAAACATTCCCTGGCTGGGCTG
AAGGGGAATGTGGGACAGAGCTCATCCCCAGGGGCCAGGGCCAGGTTCCCCCCCCCCAAGCCCGCACTCCAGGAGCC
AGCACACACAGCCCCACAGCTCAGCCCCCCCCTCCTCTGATCACTCTGCCCAGAACCACCTCCTGCCTCAGGCACTCA
CCTTGTACCAACACCTCTGTCCTGCAGCTCCCGGTGCCGGCACCCCGCTCTGCTGCTCGCCCAGCTCTGCTCCCCAGCG
TCAGCATGCAGAGACCGACCGTTAGGAATGCCTGCAGCTGCCGTCCCCAAAAATACCCTCCGATGACATGCCGGGGT
GATAAGGCTGAGTCTGCTCCATGCAGCGCCTCGGCGGGGCAGGGCTGCCCTATGTATAGCACAGGCGGGCAGCACAG
CGGCAGCGGGGCGCAGCAGACCTGTTCCTGGTGGGTGCGGGTTCAGCCCATGGCACTGCACTGTGCACGGCACGCAG
CATAGGGATGGGATGCGCTGCAGCCAGCCAGGCCGAGTGGCACTGTGGGACCCTTCTCTTGTAACTGCCACAGTGTCC
CAAACTCTGTCCAATGCTGTCTCCAGCCATGGCCTGTCCCCAAGCAGAGGGTCCCTGTTCCCGCTTTTCCTCGTGTTCC
CAGTGCCCCACTTGTTGTGGCAATGCCACTGCCCTGAACCTTGCATCCTTGGGGCGTCCCATCCATACCCAGTAAGAG
GGCACCCAGCCTGCCACCCTCCTGTGCCTCTCACGCTGTTGCTCTGCCCGACGTGCACCCTTGGCCTCCTGCTGGCCCC
CAGACTCCAGCATGGAGGCACCCAGCTGCAGGCCCCCACGCCCCCTCCATCCCTGCCTACCCCCAGCCCCACGCACTC
ACCACTCCAGCAGCATGCACCCCACCCACCCCCCTGCCTGGGCGCCGTCCCCCCCCCAGACCACACTGTCCTTGCAGT
CCTCACATTCCAGACGTCTCAGTGCTTTCACTGCCCAGAGATAATATTCACGGCGAGCAGACATTTGCGTCAGTGTCA
GATACGTCTCAATGCCACCCTGCCCCAGGGGGAGCGCAGCGGGCAGACGGGCCGGGCTGGCAAGTAGGAGCCCACG
GC AGAGCCCCTTGAGCTGCCCCACGGCC3 ’

Textbox 1: Inhibin-a subunit gene promoter sequence - 1lObp from the 3’ end of the
sequence is the non-canonical CRE sequence (yellow hi-light) which is the proposed ICER
protein binding site
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reflNT 039674.7lMm18 39714 37
strain C57BL/6J Length=73639148

Mus musculus chromosome 18 genomic contig,

Features in this part of subject sequence:
cAMP responsive element modulator
Score = 230 bits (124), Expect = 9e-58
Identities = 140/148 (94%), Gaps = 0/148 (0%)
Strand=Plus/Minus
CAGGGAAGCTGCCAGAGAATGTCGCAGGAAGAAGAAAGAATATGTCAAATGTCTTGAAAA

GG

Il I II I II 11111 I II 111111111111111111111111 II I il 111111111111
CAGGGAAGCTGCCCGGGAGTGTCGCAGGAAGAAGAAAGAATATGTCAAATGTCTTGAAAA

MM

TCGTGTGGCTGTGCTTGAAAACCAAAACAAGACTCTCATTGAGGAACTCAAGGCCCTCAA

GG

II II 11111111111111111 1111 II 11111 I II 1111111 II 11111111111111
TCGTGTGGCTGTGCTTGAAAATCAAAACAAGACCCTCATTGAGGAACTCAAGGCCCTCAA

MM

AGATCTTTATTGTCATAAAGCAGAATAA

GG

III l l l l l l l l

I I I I I I I I I I I III

AGACCTTTATTGCCATAAAGCAGAGTAA

MM

Textbox 2: Gallus gallus ICER Iy mRNA alignment with Mus musculus ICER Iy mRNA results indicate 94% identity match b/w the mouse and chicken ICER mRNA
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Figure 2: New England BioLabs NebCutter analysis data for Inh-a subunit gene promoter
Sequence- the value of 66% GC content was my main consideration for setting the
PCR parameters.
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Figure 3: Restriction enzyme map for Inh-a subunit gene promoter sequence - restriction
sites represent location for a single point cut for each respective enzyme listed. The
indicated map was used to calculate the expected band size following restriction digest with
the respective enzyme
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Figure 4: New England BioLabs analysis data for gg-ICER Iy gene sequence
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Figure 5: Restriction enzyme sites for gg-ICER Iy sequence (single point cutters)
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Table 1: NanoDrop data for chicken genomic DNA - multiple samples listed indicate
distinct extraction of chicken ovarian DNA (multiple ovaries used)
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DNA/RNA Extraction
Following the TRIzol protocol for nucleic acids extraction, ~ 1ml of both DNA and RNA
was extracted from chicken ovaries and purified for later experiments. The results obtained
from the NanoDrop spectrophotometer for the purified genomic DNA are listed in Table 1.
The purified RNA was run on 1% Agarose gel to verify the integrity of the purification
procedure. Fg.6 clearly identifies two bands representing RNA derived from the 28S and
18S ribosomal subunits, confirming total RNA extraction.

RT-PCR
Amplification of the gg-ICER Iy sequence starting from mRNA was successfully
completed and the amplified DNA product was run on 2% agarose gel. The amplified
sequence did fit the range of ~ 320bp, which was the expected size of the gg-ICER Iy gene
product (Supp. Fg.2). gg-ICER Iy was then initially subcloned onto the pCR-2.1 Topo
vector and restriction digested with EcoRI. As predicted by the restriction mapping
analysis, this event produced two distinct bands, the gg-ICER Iy with ~320bp and the
larger band representing the remaining of the linearized plasmid sequence with ~4000bp
(fg.7A). gg-ICER Iy was then transferred onto the pFLAG-CMV-2 expression vector.
Using EcoRI, once more we confirmed the restriction digest pattern and showed that we do
have the gene sequence amplified (fg.7B). In addition, in a separate restriction digest
experiment using EcoRI and Bglll restriction enzymes, we were able to calculate the
expected band pattern on the agarose gel and verify samples with correct orientation of the
ICER gene insert on the plasmid. Only those samples indicating correct orientation of ggICER Iy were later sent for sequencing (data not shown)
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28S

18S

Figure 6: Gallus gallus RNA on 1% Agarose gel - following genomic RNA extraction
A)

A)
B)

1

2 3 4

B) 1

2 3 4 5

pCR-2.1 Topo-gg-ICER Iy EcoRI (lane 1-4 indicate successful subcloning)
pFLAG-CMV-2 gg-ICER Iy EcoRI (lane 1-5 indicate ICER digest)

Sample ID: RVS 3hx CMV-Forward_C09.abl
CGGGGGCNT AGCGAGCTGTTNGTGAACCGTC AGAATTGATCT ACC ATGGACT AC AAAGACGATGACGAC A
AGCTTGGTACCGAGCTCGGATCCACTAGTAACGGCCGCCAGTGTGCTGGAATTCGCCCTTATGGCTGTTAC
AGGAGATGAAACAGCTGCCACTGGAGACATGCCATCTTACCAGCTTCGGACTCCCACTACTAACTTACCT
CAGGGAGTGGTAATGGCAGCCTCCCCAGGGGCTCTGCATAGTCCTCAGCAACTGGCAGAAGAGGCAACG
CGCAAGAGAGAGCTGCGACTTATGAAAAACAGGGAAGCTGCCAGAGAATGTCGCAGGAAGAAGAAAGA
ATATGTCAAATGTCTTGAAAATCGTGTGGCTGTGCTTGAAAACCAAAACAAGACTCTCATTGAGGAACTC
AAGGCCCTCAAAGATCTTTATTGTCATAAAGCAGAATAAAAGGGCGAATTCTGCAGATATCCATCACACT
GGCGGCCGCTCGAGCATGCATCTAGAGGATCCCGGGTGGCATCCCTGTGACCCCTCCCCAGTGCCTCTCCT
GGCCCTGGAAGTTGCCACTCCAGTGCCCACCAGCCTTGTCCTAATAAAATTAAGTTGCATCATTTTGTCTG
ACTAGGTGTCCTTCTATAATATTATGGGGTGGAGGGGGGGGTGGTATNNNNNNNNNNNNNNNNNNNNNN
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
NN

Textbox 3: gg-ICER Iy DNA sequencing data (GenWiz)
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DNA Sequencing (gg-ICER Iy)
To confirm the gg-ICER Iy sequence, plasmid sample containing the gg-ICER Iy
sequence was sent for sequencing done by GeneWiz. The produced sequence was then
aligned with the NCBI generated sequence in order to compare the efficiency of the
amplification reaction. The resulted sequence had 100% match in nucleotide comparison
with Gallus gallus mRNA for ICER Iy (NCBI accession # AF509471,Suppl fg.l) The
sequencing data provided additional evidence for orientation of the gg-ICER Iy gene
insert onto the plasmid. The collective data enabled continuation with the subcloning of
the Inh-a subunit gene promoter sequence on the grounds of correct orientation of the
gene sequence. In addition to the sequencing data, we performed another restriction
digest reaction using three different restriction enzymes: EcoRI, Xbal and Hindi. Based
on the pFLAG-CMV-2 plasmid map and our collective restriction map for gg-ICER Iy
we were able to calculate the expected band sizes for each digest individually. Our focus
was excision of the gene sequence using EcoRI, excision of the CMV promoter sequence
using Hindi and a control digest using Xbal that would only make a single cut on the
MCS and linearize the plasmid. Following an agarose gel run, we were able to determine
the experimental results matching our calculated data. Using three different restriction
enzymes, EcoRI, Xbal and Hindi, we were able to excise the gene insert, linearize the
plasmid and excise the CMV promoter (fg.8). The last event, excision of the CMV
promoter produced a plasmid with the gg-ICER Iy gene incorporated into it and available
to directly subclone the Inh-a promoter sequence, (fg.8, lane 4)
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1

2

3

4
Figure 8: Agarose Gel analysis following EcoRI,
Xbal and HincII digest
Lane 1: Molecular Marker
Lane 2:band: ~ 4700 and ~ 350 (EcoRI digest)
Lane 3: band: ~ 5060 (Xba digest)
Lane 4: band: ~ 4550 and ~ 520 (HincII digest)

~520bp
~350bp
B)

~ 3000bp
A)

~ 3000bp

Ligure 9: Inh-a Accu-Prime GC-Rich amplification on 1% agarose gel (w/ EtBr)
- fg.9A and fg.9B represent two separate amplification experiments
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PCR amplification of the Inh-a subunit gene promoter
Using thermo-stable polymerase specific for GC-rich templates we successfully amplified
the ~3046bp sequence of the Inh-a subunit gene promoter sequence. Two reactions carried
under same conditions were concluded to contain this sequence following an agarose gel
run. A distinct band at ~3kb, based on the molecular weight marker was identified, as
expected based on the in silico analyzed sequence for the Inh- a subunit gene promoter
(fg.9) Following the initial PCR amplification of the Inh-a subunit gene promoter sequence
we performed several additional amplification reactions in order to produce sufficient
amounts of the insert, to be used for subcloning and further analysis. However, at the time
of the initial analysis, we were able to excise and collect the gel piece containing the DNA
band of the expected size. Using the gel extraction/purification protocol specified in the
materials and methods section, the isolated DNA was prepared and the integrity was again
verified using agarose minigel (fg.10). As a result of the specific amplification method used
to amplify the Inh-a subunit gene promoter sequence, namely the Accu-Prime GC-Rich
polymerase, we then used pCR Blunt II-Topo plasmid to subclone the insert. The Topo
cloning reactions yielded significant number of bacterial colonies that grew selectively on
LB plates with kanamycin. Bacterial colonies were used to grow 44 minicultures overnight.
In addition to the pCR Blunt II-Topo, we also used the previously generated pFLAGCMV-2 plasmid and performed a T4 ligation using three different concentration of our
PCR amplified insert. This time, however, we used the Hindi digested pFLAG-CMV-2
without the CMV promoter sequence containing the gg-ICER Iy in the MCS. LB plates and
minicultures were amp selective.
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Figure 12: Confirmation digest of the
pCR-Blunt II-Topo - BamHI
restriction enzyme used
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Following the BamHI restriction digest (fg.l 1) a single sample was observed to have two
distinct bands with approximately 3.5 and 3kb, based on the molecular weight marker. As
projected based on the restriction mapping analysis, the 3.5 band represents the linearized
pCR-Blunt II-Topo plasmid and the lower band represents the ~ 3000bp sequence of the
Inh-a subunit gene promoter. Collectively, these data indicated successful ligation of the
Inh-a subunit gene promoter sequence to the pCR-Blunt II-Topo plasmid. A sample
reaction thus was prepared and sent for sequencing. In addition to the DNA sequencing
analysis results (textbox 4) and sequence alignment, along with our restriction mapping
data, we were able to conclude that the observed two bands are actually a Topo-Topo self
ligation where the pCR-Blunt II-Topo plasmid was ligated to itself. Additional analysis
provided evidence that due to the presence of a specific restriction site (GGATCC) for
BamHI (fg.l2) the two bands were seen. In a rare coincidence situation the two bands of
the unexpected self ligation reaction matched the expected size for the Inh-a subunit gene
promoter sequence and the pCR-Blunt II-Topo plasmid.
Protein Extraction, SDS-PAGE and Western Blot
Parallel to the Inh- a amplification experiments I performed several cell transfection
experiments (see Supp. fg.4). As a results of the induced 293T-cell protein expression, I
was able to collect the protein extract, as specified in the materials and methods section.
The purified protein extract was then used to perform an SDS-PAGE and Western Blot.
The nitrocellulose membrane was incubated and stained with anti-ICER and anti-FLAG
primary antibodies. Our results indicated that gg-ICER Iy was transferred from the
polyacrilamide gel and stained positively for anti-ICER Ab (fg.l4). This confirmed
expression of gg-ICER Iy under the control of the strong CMV promoter located upstream
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on the pFLAG-CMV-2 plasmid’s MCS. Successful expression the of the gene construct
was a requirement for continuation with the of subcloning the Inh-a subunit gene promoter
as a replacement of the CMV promoter.

Q-RT-PCR of w.t. and transgenic mouse cDNA
Collective data of multiple Q-RT-PCR reactions were analyzed for amplification of initial
mRNA levels. The analysis were based on the fluorescence readings accumulated by the
MX3000P software (Stratagene) and calculated for each cycle of the Q-RT-PCR with total
of 40 cycles. Our starting samples were prepared using cDNA derived from transgenic and
wild type mice (Molina et al., manuscript in preparation) Using these data inputs we then
calculated the ratio between the house-keeping gapdh gene fluorescence levels and Inh-a
gene fluorescence levels for each specific sample used. The ratio of gapdh/Inh-a of wild
type mice were used to set reference mRNA translational levels. Using the wild-type
calculated ratio of gapdh/Inh-a I was then able to compare the mRNA levels of transgenic
animals and determine if Inh-a expression in animals carrying ICER transgene is
downregulated, unaffected or induced (fg.14 and Supp. fg.5).
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C NANATG CNTG CTCG AG CG G CCG CCAG TG TG ATG G ATATCTG CAG AATTCG CCCTTAG G CG A
G G ATCCg ag ctcgg taccaagcttg atg cata
G C TTG A G T A TT C T A T AG TG TC AC C T A A A T AG C TTG G C G TA A T C A TG G TC A TA G C TG TTTC C TG

attccag cacactgg cg g ccg ttactagt

TGTGAAATTGTTATCCG CTCACAATTCCACACAACATACG AG CCGG AAG CATAAAGTG TAAA
G C C TG G G G T G C C T A A T G A G T G A G C T A A C T C A C A T T A A T T G C G T T G C G C T C A C T G C C C G C T T T C
CAG TCG G G AAACC TG TCG TG CC AG C TG CATTAATG AATC G G CC AAC G C G C G G G G AG AG G C G
G TTTG C G TATTG G G C G C TCTTCC G C TTCCTCG CTCACTG ACTCG CTG C G C TCG G TCG TTCG G C
TGCGGCG A G C G G T A TC AG C TC A C TC A A AG G C G G T A A T A C G G TT A TC C AC A G A A TC AG G G G A
TAACGCAG G AAAG AACATG TG AG CAAAAG G CCAG CAAAAG G CCAG G AACCG TAAAAAG G C
C G C G TTG CTG G CG TTTTTCCATAG G CTCCG CCCCCCTG ACG AG CATCACAAAAATCG ACG CT
CA A G TC A G AG G TG G C G A A ACCCG A C A G G A C T A T A A A G A T ACC AG G CG TTTCC CC C TG G A A G
CTC CC TCG TG CG CTCTCC TG TTCCG ACCCTG C CG CTTACCG G ATACCTG TCCG CCTTTCTCCCT
TCG G G AAG CG TG G G CG CTTTCTCATAG CTCACG CTG TAG G TATCTCAG TTCG G TG TANG TCG T
TCG CTCCAAGCTG GG GCTG TGTGCACGAACCCCCCG TTCAG CCCG ACCGCTG CG CCTTATCC
G G TAACTATCG TCTTG AG TCC C AC CC G G NAAG AN AC G AC TTATN G C C NC TG G N AG C AG CC NC
TGNT A A N AGG A T T ATC ANAN CG AG G NTTN .

Textbox 4: DNA sequencing output for Inh-a subunit gene promoter on pCR-Blunt IITopo (BamHI restriction site in red)

A)

B)

Figure 13: EcoRI restriction digest of A) pCR-Blunt II-Topo and B) pFLAG-CMV-2 ggICER y plasmids carrying Inh-a promoter. Both pictures represent agarose gels following
plasmid extraction and EcoRI restriction digest.
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12kDa

Figure 14: Western Blot for gg-ICER Iy using anti-ICER primary antibody

Q-RT-PCR of w.t. vs transgenic gapdh/lnh-alpha

□ w.tID 138(Gapdh/lnha)
QTg ID 115(Gapdh/lnha)
□ Tg ID 111(Gapdh/lnha)

Cycle Number

Figure 15: Q-RT-PCR output data for w.t. and transgenic cDNA amplification rates plotted
as factor of fluorescence (mouse cDNA) - graph indicated that levels of Inh- a in
transgenic animals is significantly downregulated, compared to the levels of expression in
wild-type animals.
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DISCUSSION
Transgenic animals including rodents and avian models became suitable systems for
studies on gene function and gene interactions and have been used to unlock the
mechanisms involved in specific developmental and reproductive processes. Comparative
studies using nucleic acids and protein samples derived from wild type and transgenic
animals represent a reliable method for validating specific genes and their involvement in
specific processes. In addition, following the recent advances in the DNA microarray
technology, studies of the expression patterns between wild type and transgenic animals
became reliable tool for discovering specific genes that are induced or repressed as a result
of the specific mutation introduced to the newly modified animal model.
CREM and ICER isoforms of activators and repressors in multiple studies have
been implicated to regulate processes related to the reproductive system as well as the
neuroendocrine and the nervous system (Mukherjee et al, 2003). ICER has been reported
to be the smallest nuclear transcription factor known with only 108 amino acid in its
sequence. ICER has also been reported to be the only inducible isoform of CREM exerting
its function as dominant negative transcriptional repressor. Representing the last signals of
the well studied cAMP relay, CREM and ICER constructs have been developed for
different animal models. The role of ICER in folliculogenesis however has not been fully
validated since there is no ICER-null rodent model yet developed (Molina et al,
manuscript in preparation). Developing a mouse model where ICER expression was
disrupted and ICER role was examined based on the newly introduced expression pattern
was indeed a very useful tool for implicating this CREM isoform in the folliculogenesis,
spermatogenesis and in the reproductive system in general (Molina et al, manuscript in
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preparation, William and Habener, 1996). In thus current study my focus was to generate a
FLAG-ICER transgenic construct specific for the domesticated hen, Gallus gallus. My
perspective was derived from several key benefits from developing an avian model
carrying ICER transgenic construct regulated by an ovarian-specific promoter. From an
economic stand point, genetically modified avian model with inducible ovulation rates may
directly translate into increased food production. In chicken, hyperovulation would mean
increased egg production per animal unit, a factor that is a great interest for the biotech
sector and the poultry industry in general. Increased egg production would directly translate
into significant increase of monetary gain. The hyperovulation rate had two-fold increase in
rodents (Molina et al, manuscript in preparation). From scientific perspective, a plausible
effect would be the molecular mechanism involved in the reproductive system and the
clues that may be unlocked by generating a hyperovulating system under hormonal (FSH or
LH) or cAMP-inducible control. On the other hand, recent studies are focusing on
generating avian transgenic animals with the ability to serve as natural bio-reactors for
production of therapeutically relevant proteins that in other cases require costly
manufacturing processes. The idea for developing avians as protein bio-reactors may
simply come out from the fact that a single egg contains ~3.6g of albumin protein (Lillico
et al, 2007). Shifting from albumin production to a protein of interest can thus be made
possible by designing specific transgenic constructs that will utilize the natural avian
mechanism for protein production. For these specific goals, I focused on the domesticated
hen, Gallus gallus. Among the reasons for using avian animal model are the availability
and research-cost efficiency, previous work already reporting significant advances in gene
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delivery as well as the availability of the completed chicken genome from the NCBI
database (http:// www.ncbi.nlm.nih.gov/projects/ genome/ guide/chicken).
For the purpose of generating ovarian-specific construct, I amplified the 3kb
Inhibin-a subunit gene promoter which has been implicated as site for transcriptional
activation by CREB in response to FSH (Molina et al, manuscript in preparation). The
Inh-a subunit gene has tissue-limited expression thus making it suitable promoter sequence
for transgene construct targeted for ovarian expression only. Inhibin-a subunit gene
expression is limited to the ovaries, gonads, the pituitary gland and placenta, however, only
by using the entire 3kb promoter sequence of the Gallus gallus Inh-a I hypothesize that the
transgene expression will be limited to the ovaries only. My hypothesis is derived from the
data acquired from study done on rodents (Molina et al, manuscript in preparation). The
3kb promoter sequence of the Inh-a gene has not been amplified up to this date. Our
hypothesis extends that under the control of the FSH inducible Inh-a promoter we can
over-express FLAG-ICER transgene and induce hyperovulation. Using a sequencehomolog construct, specific for mice, two-fold rate increase in ovulation was observed
(Molina et al, manuscript in preparation). Analyzing the sequences for Inh-a and ICER
between rodents and avian, I found 94% identical nucleotide arrangement thus I expect to
see similar expression patter in Gallus gallus.
Inh-a subunit gene promoter was found to be ~3kb in size and 66% of GC content.
Using the method indicated in the material and methods section, I was able to amplify this
sequence and our agarose gel results showed the expected band size. Presumably, due to
the size of the promoter and the high GC content, I was not able to neither repeat the
amplification by performing direct PCR of genomic DNA nor re-amplify the PCR product.
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For this reason I re-designed and used multiple primers sets specific for the Inh-a promoter
sequence (suppl. fg.3) Every primer set used was re-designed and optimized for different
annealing temperature, a factor that I gave priority when adjusting the PCR parameters. In
addition, in multiple reactions I changed the primer concentration and the cycling
parameters. The results of the new PCR conditions did not show any particular effect.
Studies reporting amplification of high GC templates suggested that this lack of
amplification efficiency may be due to the shorter readable sequences as a result of
formation of distinct secondary structure (Choi et al, 1999). For that reason I validated
several key factors including changes in the DNA concentration and concentration of
buffers and additives (DMSO, MgS04). A 5% v/v DMSO was reported to increase
denaturation of the dsDNA and increase the length of the segment amplified at any given
time. No significant changes were observed following multiple adjustments made with
DMSO and MgS04, using one alone or together (Choi et al, 1999). Next, I focused on
testing different thermostable enzymes. These enzymes include the adjustments made to
the initial Accu-Prime protocol (Invitrogen) the HotStart Tag Plus DNA Polymerase
(Qiagen) and the HotStart Tag Mastermix (Denville scientific). I observed relatively small
changes in amplification efficiency between different enzymes used, however all results
lacked re-amplification of the expected sequence.
Following the extraction of DNA and RNA from chicken ovaries we successfully
amplified both gg-ICER Iy and Inh-a. I then used multiple cloning and expression plasmids
to produce larger amount of the gene and the promoter sequences. gg-ICER Iy was initially
subcloned onto pCR Topo and later transferred onto pFLAG-CMV-2 plasmid. Under the
control of the strong CMV promoter I was able to express the ICER gene following 293T
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(Human Kidney Carcinoma) cell transfection. Western blot analysis provided evidence for
gg-ICER Iy expression, staining positive with anti-ICER primary antibody. At the same
time, DNA sequencing analysis provided additional confirmation for the integrity of the
amplified sequence. The BLAST and alignment data showed 100% nucleotide match with
the known chicken (Gallus gallus) sequence, initially found on the NCBI database
(AF509471). In addition, I was able to construct a variation of the original pFLAG-CMV-2
plasmid by removing the CMV promoter. Using the HincII restriction enzyme we observed
band pattern characteristic for linearized plasmid without the promoter sequence. This
variation of the pFLAG-CMV-2 plasmid was later used for subcloning the Inh-a subunit
gene promoter sequences upstream of the gg-ICER Iy located on the multiple cloning site.
My initial data for the Inh-a promoter provided evidence for successful amplification of the
3kb sequence. I was able to surpass the main obstacle for amplifying a large construct with
over 66% GC content using specific thermo stable DNA polymerase. Due to the specific
amplification mechanism of the Accu-Prime polymerase enzyme, which generates
sequences with blunt ends, I used pCR-Blunt II-Topo subcloning plasmid designed to
incorporate blunt end sequences. To further increase the ligation rates, I de-phosphorylated
the PCR product, which resulted with high yield bacterial colonies growth on amp-selective
plates. I am next focusing on subcloning our final construct, Inh-a-FLAG-gg-ICER Iy and
test for expression in cell culture. The final stage would include the transfer onto lentiviral
vector that would be used as vehicle for delivering the transgene construct into fertilized
chicken eggs, as a first step towards creating a transgenic chicken.
In addition to the molecular cloning of the Inh-a-FLAG-gg-ICER Iy transgene
construct, I also focused on further analysis of mouse-derived cDNA. Namely, I performed
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Q-RT-PCR and analyzed the levels of gapdh and Inh-a genes taken from wild type and
transgenic animals. Inhibins have been shown to have limited expression in several tissues
through the organism including the granulosa cells in females and sertoli cells in males
(Shao-Yao et al, 1995, Safi et al, 2002, Chen et al, 2007). The levels of Inh-a have been
reported to increase at the pre-antral stage of follicular development reaching its peak at the
antral stage (Johnson et al, 2005). In the process of folliculogenesis, the antral or the
tertiary phase represents the survival gate, when most of the follicles get arrested and sent
for follicular atresia. The mechanism behind the follicular atresia and the molecular cues
that initiate termination of development remain unknown. Several studies however have
reported that following the increase expression of Inh-a in granulosa cells, the levels of
FSH produced in pituitary gland are decreased (Safi et al, 2002, Bernard et al, Chen et al.,
2007). The proposed mechanism suggests that Inh-a closes the negative signal loop that
shuts down FSH production. Consequently, as a result of the FSH deficiency, found also at
the antral stage, the follicular development is terminated for most of the developing
follicles, followed by the initiation of the follicular atresia. My results support this
hypothesis. In wild-type mice, following the initial increase in expression of Inh-a, the
levels reach a peak expression after which a stabilization is observed. The levels of Inh-a
were calculated setting the levels of the house-keeping gapdh gene as a reference line
(Molina et al, manuscript in preparation). In transgenic mice, however, the results were
dramatically different. Following the initial increase in expression, Inh-a levels were found
to be down-regulated, almost bringing it as low as the initial starting point levels. My
hypothesis is that ICER Iy overexpression, in transgenic mice, is repressing Inh-a gene
expression by binding to the CRE sequence located on the Inh-a promoter. By doing so,
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ICER is prolonging the FSH surge coming from the pituitary gland. Prolonged FSH
production is then increasing the number of the developing follicles rescued from follicular
atresia. The same observation I found repeating the Q-RT-PCR experiment twice, using a
total of 2 wild-type derived cDNA and 4 transgenic cDNA samples. These result, however,
were not observed when a DNA microarray analysis was performed (Molina et al.,
manuscript in preparation). This effect may be due to the fact that at different stages of the
mice estrous cycle, different expression patterns are regulating the processes of
folliculogenesis, ovulation and follicular atresia, as well as the coordination between them
all.
In this study I have shown data for successful cloning of the Gallus gallus
Inducible cAMP Early Repressor (ICER Iy). Following the RT-PCR amplification of the
chicken RNA ICER Iy, I performed several restriction digest reaction and verified the
orientation of the gene, now ligated onto the pFLAG-CMV-2 plasmid. Placed under the
control of the strong CMV promoter, I was able to induce gg-ICER Iy expression in 293T
(Human Kidney Carcinoma) cells and detect the gene expression using an antibody
specifically designed for ICER Iy. Western Blot analysis indicated expression of the target
gene with the expected ~12kDa in size. Finally, our sequencing data indicated complete
nucleotide sequence match of the amplified gg-ICER Iy. The sequence alignment data
(NCBI Blast) showed a 100% match with published sequences of Gallus gallus ICER Iy. I
can partially confirm amplification of the Inh-a subunit gene promoter sequence. The
initial observation on the agarose gel indicated a 3kb band, as expected for the generated
promoter sequence (European Bioinformatics web page). Following the subcloning
reaction, I was able to confirm the right band patterns, using restriction enzymes specific
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for the used pCR Blunt II-topo plasmid and the Inh-a sequence. I wasn’t able to confirm
the correct sequence following the sequencing experiment. My focus is now the re
amplification of the Inh-a sequence and ligating it to the pFLAG-CMV-2-gg-ICER Iy
plasmid. Important feature of this plasmid is that the CMV promoter has been excised out
by a specific HincII digest. A complete construct of Inh-a-FLAG-gg-ICER Iy can then be
tested in cell culture and prepared for lentiviral gene delivery into the host avian animal.
Developing a transgenic colony carrying our construct can then be analyzed for several
developmental and reproductive features, including the FSH regulated hyperovulation as
part of my main hypothesis.
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SUPPLEMENT DATA AND FIGURES
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gb|AF509471.1| 1 k£j Gallus gallus ICER mRNA, complete cds
Length=327
GENE ID: 378903 ICER | ICER protein [Gallus gallus]
Score = 566 bits (306), Expect = 5e-158
Identities = 306/306 (100%), Gaps = 0/306
Strand=Plus/Plus
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Supplement figure 1: Mega-BLAST analysis using the nucleotide sequence generated from
the DNA sequencing experiment of the pFLAG-CMV-2-gg-ICER Iy. Results indicate
100% match b/w the amplified ICER and the NCBI published sequence for ICER gene
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Supplement figure 2 RT-PCR Agarose gel of ICER Iy (arrows indicate band for ~320bp
ICER Iy

Forward primer: 5’ GCTCCGCCACCTCCACGTCC 3’
Reverse primer: 5’ GGCCGTGGGGCAGCTCAAGG 3’
Supplement figure 3 Inh-a amplification primers (additional set)
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Supplement figure 4 Cell Transfection of gg-ICER Iy:
Plate 1 pFLAG-CMV-2 gg-ICER Iy
Plate 2 pSV-mm-ICER Iy control
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Q-RT-PCR of w.t. vs transgenic gapdh/lnhalpha
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Supplement figure 5 Q-RT-PCR of w.t. vs transgenic gapdh/Inh-a (mouse cDNA)
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